Tag Archive for: amivantamab

Amivantamab in combination with Lazertinib showed efficacy in NSCLC

Amivantamab in combination with Lazertinib showed efficacy in NSCLC

Non-small cell lung cancer (NSCLC) accounts for 80-85% of all lung cancer. The most frequent genetic mutation harboured in lung adenocarcinomas occurs in the epidermal growth factor receptor (EGFR), accounting for 40-55% in Asian patients.